Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Search
Medicines Law & Policy
Research and resources on intellectual property and health
Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Tag: WHO
Protecting Public Health through Technology Transfer: The Unfulfilled Promise of the...
Ellen 't Hoen
-
March 16, 2023
ML&P’s Comments to the Intergovernmental Negotiating Body (INB) on the Zero...
Ellen 't Hoen
-
February 28, 2023
Medicines price transparency: Ground still left to cover
Katrina Perehudoff
-
February 3, 2023
Wrapping up 2022 with some noteworthy medicines, law and policy events
Medicines Law & Policy
-
December 22, 2022
Seven recommendations for sharing intellectual property, know-how and technology – report...
Medicines Law & Policy
-
July 18, 2022
With technology transfer, 120 companies in low- and middle-income countries could...
Kaitlin Mara
-
February 15, 2022
Wrapping up 2021 – some noteworthy medicines law and policy events
Ellen 't Hoen
-
December 24, 2021
Landmark decision by the World Health Assembly to start negotiations for...
Kaitlin Mara
-
December 1, 2021
Imagine if health and trade ministers would meet in one room...
Ellen 't Hoen
-
November 30, 2021
The WHO Covid-19 Technology Access Pool signs first licence agreement; will...
Kaitlin Mara
-
November 23, 2021
1
2
3
4
Page 1 of 4
This work is licensed under Creative Commons.